Johan Hyllner

发表

Transcriptional profiling of human embryonic stem cells differentiating to definitive and primitive endoderm and further toward the hepatic lineage.

Björn Olsson, Anders Lindahl, Jane Synnergren, 2010, Stem cells and development.

The application of human embryonic stem cell technologies to drug discovery.

Peter Sartipy, J. Hyllner, P. Sartipy, 2007, Drug discovery today.

Cardiomyocytes derived from human embryonic stem cells - characteristics and utility for drug discovery.

Peter Sartipy, Johan Hyllner, Daniella Steel, 2009, Current opinion in drug discovery & development.

Human embryonic stem cell technologies and drug discovery

J. Hyllner, J. Jensen, P. Björquist, 2009, Journal of cellular physiology.

Human embryonic stem cells: current technologies and emerging industrial applications.

Anders Lindahl, Peter Sartipy, A. Lindahl, 2008, Critical reviews in oncology/hematology.

Pluripotent human stem cells as novel tools in drug discovery and toxicity testing.

Peter Sartipy, J. Hyllner, P. Sartipy, 2006, IDrugs : the investigational drugs journal.

Coculture of Human Embryonic Stem Cells and Human Articular Chondrocytes Results in Significantly Altered Phenotype and Improved Chondrogenic Differentiation

Anders Lindahl, Camilla Karlsson, S. Concaro, 2009, Stem cells.

Comparability: manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14–15 September 2015

Anne L Plant, Ivan Wall, Glyn Stacey, 2016, Regenerative medicine.

Footprint‐Free Human Induced Pluripotent Stem Cells From Articular Cartilage With Redifferentiation Capacity: A First Step Toward a Clinical‐Grade Cell Source

Anders Lindahl, C. Brantsing, A. Lindahl, 2014, Stem cells translational medicine.

On-chip in vitro cell-network pre-clinical cardiac toxicity using spatiotemporal human cardiomyocyte measurement on a chip

Kenji Yasuda, Tomoyuki Kaneko, Peter Sartipy, 2014, Scientific Reports.